Search Results 2331-2340 of 20210 for Receptor

  1. A Study to Evaluate Immunotherapy for Non-Small Cell Lung Cancer - Mayo Clinic

    NSCLC expressing epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), B-Raf proto-oncogene (BRAF) or ROS proto-oncogene 1 (ROS1) ...

  2. Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004) - Mayo Clinic

    * Participants with genome mutations must have received 1 or 2 prior lines of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI) ...

  3. Hematology - Clinical trials

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

  4. Hematology - Clinical trials

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

  5. Hematology - Clinical trials

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

  6. Mayo Foundation Rising Stars Symposium - Speakers

    ... receptor. Endocrine resistance also is an emerging problem in the treatment of ER-expressing ovarian cancer. Dr. Nayar identified a novel class of clinical ...

  7. A Study of Idelalisib Combined with BI 836826 for Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

    For relapsed CLL most recently treated with B-cell receptor (BCR) pathway inhibitors which, in the opinion of the investigator, will not tolerate waiting 3 ...

  8. Neurology - Clinical trials

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

  9. Fusion and screening - Antibody Hybridoma Core - Mayo Clinic Research

    Since it is used for identifying cell-surface receptor molecules, FACS requires whole-cell suspensions and special cell-sorting equipment to process samples.

  10. Eculizumab-aeeb (intravenous route) - Side effects & uses - Mayo Clinic

    ... receptor (AChR) antibody positive. Eculizumab-aeeb injection is a monoclonal antibody that works on the immune system. This medicine is available only under ...